HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Friday, 8 April 2016

Cochrane Collaboration Issue 3, 2016…

….is complete.  It includes dozens of new or updated reviews, including:
  • Antibiotics and antiseptics for surgical wounds healing by secondary intention
  • Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
  • Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
  • Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension
  • Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI
  • Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
  • Teriflunomide for multiple sclerosis